Over-the-counter drug works well for allergies

Key points
- Contrary to what had been expected, new research shows that non-prescription pseudoephedrine controls nasal allergy symptoms just as well as the more expensive prescription drug Singulair, also known by its generic name, montelukast.
- In fact, for nasal congestion, pseudoephedrine may provide better relief.
- "We had expected the drugs to perform similarly in controlling nasal congestion, but we thought montelukast would provide better relief against sneezing, (runny nose), and nasal itching," Dr.
- While pseudoephedrine is known to be an effective treatment for nasal congestion caused by allergies, it was not thought to be particular useful against other symptoms.
Contrary to what had been expected, new research shows that non-prescription pseudoephedrine controls nasal allergy symptoms just as well as the more expensive prescription drug Singulair, also known by its generic name, montelukast.
In fact, for nasal congestion, pseudoephedrine may provide better relief.
"We had expected the drugs to perform similarly in controlling nasal congestion, but we thought montelukast would provide better relief against sneezing, (runny nose), and nasal itching," Dr. Fuad M. Baroody, from the University of Chicago, told Reuters Health. "We were surprised that both drugs did about the same."
While pseudoephedrine is known to be an effective treatment for nasal congestion caused by allergies, it was not thought to be particular useful against other symptoms. Moreover, some people who take pseudoephedrine experience side effects such as insomnia and nervousness.
Baroody's team anticipated that treatment with montelukast would provide broader symptom relief than pseudoephedrine and would be better tolerated.
The study, which appears in the Archives of Otolaryngology - Head and Neck Surgery, involved 58 adults allergic to ragweed who were randomized to receive a once-daily morning dose of pseudoephedrine or montelukast for 2 weeks.
Treatment with either agent provided similar and significant improvements in all aspects of quality of life. As noted, pseudoephedrine was more effective than montelukast at controlling nasal congestion, but otherwise the agents provided comparable symptom relief.
The tolerability of the agents was similar with no increase in insomnia or nervousness seen with pseudoephedrine. The researchers chalk this up to pseudoephedrine being given as one higher dose in the morning, rather than as two or more lower doses given throughout the day as is often done.
"When people pick up pseudoephedrine over the counter, most of them pick up the twice-a-day dosing," Baroody noted. "If you take a dose before bedtime, there's a good chance that you will experience insomnia or jitteriness."
People "can start with pseudoephedrine, take it, and if it doesn't give you side effects then you're fine," Baroody advised. "But, if it gives you side effects or you're not getting complete relief, there are a number of prescription medications that are more effective," he emphasized.
SOURCE: Archives of Otolaryngology - Head and Neck Surgery, February 2006.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →
NewsOral drops can give kids needle-free relief from asthma, allergies
Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial - and stick-free - option for pediatric allergy sufferers,…
6 May 2013
NewsU.S.-born kids have more allergies, asthma
Kids and teens who are born abroad and immigrate to the United States are about half as likely to have asthma and allergies as those who are born in the U.S., according to a new study. Researchers surveyed the parents…
30 April 2013
NewsHave asthma? You likely have an allergy as well
Asthma is becoming an epidemic in the United States. The number of Americans diagnosed with asthma grows annually, with 26 million currently affected. And according to a new study, nearly two-thirds or more of all…


